EliseAI vs Hyro
If your failure mode is choosing on a containment headline without asking whether the agent completes the task or merely routes it, this pair separates enterprise depth from multi channel breadth. Hyro is the enterprise build: the clearest architecture in the lane, a hybrid of large language models, a proprietary conversational engine, small healthcare tuned models, and knowledge graphs, with direct API into Epic and CRMs so it books and refills rather than answers, deployed across 45 to 50 health systems with an investing client. EliseAI is the broader channel play, handling a reported 95 percent of inquiries across voice, text, email, and chat with more than 50 languages, and publishing SOC 2 Type 2. Hyro if you are a large system that wants a controllable, transaction completing agent. EliseAI if you want wide channel coverage across the front office.
- Multi channel by design: one agent across voice, text, email, and chat with more than 50 languages, a reported 95 percent inquiry containment, and booking directly into the EHR.
- A stated SOC 2 Type 2 and HIPAA posture published on the product pages, which is a cleaner certification claim than Hyro's records carry here.
- Positioned for healthcare operations broadly rather than only large enterprise systems, if channel breadth matters more than deep enterprise integration.
- The clearest architecture in the index among voice vendors: a documented hybrid of LLMs, a proprietary conversational engine, small healthcare tuned models, and knowledge graphs, so a buyer can interrogate how the agent is constrained.
- Completes transactions through direct API into Epic and CRMs, booking and refilling rather than routing, which separates it from IVR replacement, backed by 45 to 50 health systems and an investing client.
- Independently corroborated enterprise adoption and third party recognition, including Fierce Healthcare's 2026 Fierce 15, a stronger evidence position than partner reported containment alone.
Side-by-Side
| Axis | E EliseAI |
H Hyro |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | — | |
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | — | — |
| HIPAA and BAA Posture | — | |
| Security Certifications and Trust Center | — | |
| FDA and Regulatory Status | — | — |
| AI Governance and Bias Disclosure | — | — |
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | — | — |
| Commercial Transparency | ||
| Setting and Specialty Coverage | — | — |
Both are graded on vendor reported operational metrics without independent validation, and containment definitions vary widely across this category, so EliseAI's 95 percent and Hyro's up to 85 percent are not directly comparable without knowing each vendor's definition of a handled or routine interaction. Neither publishes escalation trigger criteria, the boundary that matters for refill requests. Neither publishes pricing; Hyro is positioned as a premium tier for large systems, with smaller practices typically served by more general purpose alternatives, which may include EliseAI. EliseAI carries a graded SOC 2 Type 2 and HIPAA posture in this index while Hyro's record does not, so confirm Hyro's attestations directly. Voice accuracy can vary across accent and dialect, unquantified by either.